对 δ-阿片类受体的新型正调节剂的结构-活性关系研究
Owindeep Deo1, Vi Pham2, Sadia Alvi2
1Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.
ACS chemical neuroscience
|July 18, 2025
概括
针对三角阿片类受体 (DOR) 的新药候选药物显示出治疗慢性疼痛和抑郁症的前景. 这项研究开发了一种具有良好的安全概况的新型支架,为传统治疗提供了潜在的替代方案.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性疼痛和抑郁症经常同时发生,需要更安全,更有效的治疗方法.
- 目前用于缓解疼痛的μ-阿片类受体 (MOR) 激动剂具有严重的风险,如成和呼吸系统抑郁.
- δ-阿片类受体 (DOR) 激动剂是一种更安全的疼痛管理替代品,副作用的概况较低.
研究的目的:
- 开发新的 δ-阿片类受体 (DOR) 阳性全调节剂 (PAMs),具有提高的选择性和降低的脂性.
- 为了研究DOR PAMs的结构-活性关系 (SAR),以提高治疗潜力.
- 设计药物类似的治疗药物,针对具有特定信号通路偏好的DOR.
主要方法:
- 针对DOR PAM的SAR研究以优化选择性和类似药物的特性.
- 开发一种新的四基诺基纳索林支架.
- 对信号通路偏差的评估,偏好G蛋白而不是β-arrestin2招募.
主要成果:
- 成功开发了一种新的四基诺基纳索林支架.
- 新的支架显示了有利的G蛋白通路信号,而不是β-arrestin2的招募.
- 开发的化合物显示出具有特定信号配置的DOR向治疗的潜力.
结论:
- 这种新型的四基诺基纳基架是开发新的 δ-阿片类受体 (DOR) 治疗方法的有希望的基础.
- 这些发现可能会导致改善慢性疼痛和抑郁症的治疗方法,并减少副作用.
- 脚手架为进一步的结构和药理学研究提供了一个有价值的平台.
相关概念视频
Opioid Receptors: Overview
1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Analgesia and Pain Management
809
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
809
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.3K


